Page 4 - AnnualReport2022-23

CONTENTS

PART A: GENERAL INFORMATION PART B: PERFORMANCE INFORMATION

SAMRC’S GENERAL INFORMATION 5 STATEMENT OF RESPONSIBILITY FOR
PERFOMANCE FOR THE YEAR ENDED
A NOTE FROM THE BOARD CHAIRPERSON 6 31 MARCH 2022 21

A NOTE FROM THE PRESIDENT AND CEO 8 STRATEGIC OUTCOME ORIENTED GOALS 22
SAMRC’s Performance Information 22
ACHIEVEMENTS AND HIGHLIGHTS 10
NGS-SA Genomics Surveillance Programme 10 STRATEGIC OBJECTIVES, PERFORMANCE
COVID-19 Vaccine studies 10 INDICATORS, PLANNED TARGETS AND
ACTUAL ACHIEVEMENTS 26
mRNA Technology Transfer Hub 11
Chan Soon-Shiong and SAMRC Collaboration 12 OUR RESEARCH PROFILE 32
TRANSFORMATION AT THE SAMRC 14 RESEARCH PROGRAMMES AND UNITS 36

PARTNERSHIPS WITH OTHER COUNTRIES 17 FUNDING HEALTH INNOVATION 38
BRICS TB research network 17
GRANTS INNOVATION AND PRODUCT
South Africa-US programme for collaborative DEVELOPMENT 38
Biomedical Research 17
BRICS STI COVID-19 Projects 17 RESEARCH CAPACITY DEVELOPMENT 53
BRICS Multilateral Joint Science and SAMRC STRATEGIC RESEARCH PROGRAMMES 63
Technology Research Collaoration 18
Collaboration with George Institute, Australia 19 PROGRAMME 1: HEALTH PROMOTION
& DISEASE PREVENTION 63
Global Forum on Bioethics in Research (GFBR) 19
PURPOSE OF THE PROGRAMME 63
South Africa admitted to the International
Human Frontier Science Programme Organization 19 UNITS THAT CONSTITUTE THIS PROGRAMME 63
PROGRAMME STRATEGIC OBJECTIVES 63
RESEARCH HIGHLIGHTS UNDER
THIS PROGRAMME 64

PROGRAMME 2: MATERNAL, CHILD AND
WOMENS’S HEALTH 101
PURPOSE OF PROGRAMME 101
UNITS THAT CONSTITUTE THIS PROGRAMME 101
PROGRAMME STRATEGIC OBJECTIVES 101
RESEARCH HIGHLIGHTS UNDER
THIS PROGRAMME 102
PROGRAMME 3: HIV, AIDS, TB AND OTHER
COMMUNICABLE DISEASES 116
PURPOSE OF THE PROGRAMME 116
UNITS THAT CONSTITUTE THIS PROGRAMME 116
PROGRAMME STRATEGIC OBJECTIVES 116
RESEARCH HIGHLIGHTS UNDER
THIS PROGRAMME 117

2 SAMRC ANNUAL REPOR T 2022-23